» Articles » PMID: 31384304

What is in a Name? Parent, Professional and Policy-Maker Conceptions of Consent-Related Language in the Context of Newborn Screening

Abstract

Newborn bloodspot screening programs are some of the longest running population screening programs internationally. Debate continues regarding the need for parents to give consent to having their child screened. Little attention has been paid to how meanings of consent-related terminology vary among stakeholders and the implications of this for practice. We undertook semi-structured interviews with parents ( = 32), healthcare professionals ( = 19) and policy decision makers ( = 17) in two Canadian provinces. Conceptions of consent-related terms revolved around seven factors within two broad domains, and . comprised: parent decision authority; voluntariness; parent engagement with decision-making; and the process of enacting choice. comprised: professional responsibilities (including disclosure of information and time to review); parent responsibilities; and the need for discussion and understanding prior to a decision. Our findings indicate that consent-related terms are variously understood, with substantive implications for practice. We suggest that consent procedures should be explained descriptively, regardless of approach, so there are clear indications of what is expected of parents and healthcare professionals. Support systems are required both to meet the educational needs of parents and families and to support healthcare professionals in delivering information in a manner in keeping with parent needs.

Citing Articles

Genomic sequencing in newborn screening: balancing consent with the right of the asymptomatic at-risk child to be found.

Knoppers B, Bonilha A, Laberge A, Ahmed A, Newson A Eur J Hum Genet. 2024; 33(2):182-188.

PMID: 39134767 PMC: 11840138. DOI: 10.1038/s41431-024-01677-w.


Are We Ready for Whole Population Genomic Sequencing of Asymptomatic Newborns?.

Vears D, Savulescu J, Christodoulou J, Wall M, Newson A Pharmgenomics Pers Med. 2023; 16:681-691.

PMID: 37415831 PMC: 10321326. DOI: 10.2147/PGPM.S376083.


Information and Parental Consent for French Neonatal Screening: A Qualitative Study on Parental Opinion.

Pinel J, Bellanger A, Jamet C, Moreau C Int J Neonatal Screen. 2023; 9(2).

PMID: 37218891 PMC: 10204465. DOI: 10.3390/ijns9020026.

References
1.
. Serving the family from birth to the medical home. Newborn screening: a blueprint for the future - a call for a national agenda on state newborn screening programs. Pediatrics. 2000; 106(2 Pt 2):389-422. View

2.
Wildeman S, Downie J . Genetic and metabolic screening of newborns: must health care providers seek explicit parental consent?. Health Law J. 2002; 9:61-111. View

3.
Dormandy E, Hooper R, Michie S, Marteau T . Informed choice to undergo prenatal screening: a comparison of two hospitals conducting testing either as part of a routine visit or requiring a separate visit. J Med Screen. 2002; 9(3):109-14. DOI: 10.1136/jms.9.3.109. View

4.
Campbell E, Friedman Ross L . Parental attitudes regarding newborn screening of PKU and DMD. Am J Med Genet A. 2003; 120A(2):209-14. DOI: 10.1002/ajmg.a.20031. View

5.
Crow R, Gage H, Hampson S, Hart J, Kimber A, Storey L . The measurement of satisfaction with healthcare: implications for practice from a systematic review of the literature. Health Technol Assess. 2003; 6(32):1-244. DOI: 10.3310/hta6320. View